Időskori makuladegeneráció: vizsgálatok itt: Olaszország

In Olaszország 26 Also abroad 218

26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Where
Milan, Rome
Életkor
55 év to 64 év
People
110 worldwide
Run by
Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00
2. fázisTaking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Florence, Milan, Rome
Életkor
50 év and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
3. fázisTaking people
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Ferrara, Milan, Naples, Novara, Palermo, Rome, Turin
Életkor
50 év and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00
3. fázisTaking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Ancona, Cagliari, Florence, Milan, Rome
Életkor
50 év to 85 év
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
2/3. fázisTaking people
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
Ferrara, Milan, Naples, Rome
Életkor
60 év and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00
3. fázisTaking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Ancona, Ferrara, Florence, Reggio Emilia, Rome, Turin
Életkor
50 év and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
3. fázisTaking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Ancona, Bari, Chieti, Florence, Milan, Negrar, Perugia, Rome, Trieste, Udine
Életkor
50 év and over
People
1000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
3. fázisTaking people
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Ancona
Életkor
50 év and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
2/3. fázisTaking people
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Where
Ferrara, Florence, Milan, Rome, Turin, Udine
Életkor
18 év and over
People
250 worldwide
Run by
Eyebiotech Limited
See details and how to join2025-524894-17-00 · EU 2025-524894-17-00
2. fázisTaking people
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Where
Ancona, Bologna, Milan, Negrar, Rome, Turin
Életkor
55 év and over
People
324 worldwide
Run by
ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00
No phaseNot yet taking people in Olaszország
Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration
Where
Roma
Életkor
50 év and over
People
67
Run by
Fondazione G.B. Bietti, IRCCS
See details and how to joinNCT07554690
2. fázisTaking people
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Milan, Novara, Padova, Rome
Életkor
60 év and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00
No phaseTaking people
High Resolution Imaging OCT Study
Where
Milan
Életkor
18 év and over
People
97
Run by
Heidelberg Engineering GmbH
See details and how to joinNCT07338461
2/3. fázisTaking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Where
Udine
Életkor
50 év and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07496567
No phaseTaking people
Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment
Where
Roma
Életkor
18 év and over
People
260
Run by
Fondazione G.B. Bietti, IRCCS
See details and how to joinNCT07500324
No phaseTaking people
Visual Rehabilitation and Depression in Visually Impaired Patients With AMD
Where
Rome
Életkor
55 év and over
People
22
Run by
Fondazione G.B. Bietti, IRCCS
See details and how to joinNCT06906003
No phaseTaking people
International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
Where
Bari, Bergamo, Ferrara, Florence, Roma
Életkor
55 év and over
People
44 worldwide
Run by
VisionCare, Inc.
See details and how to joinNCT07164378
No phaseTaking people
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
Where
Trento
Életkor
50 év and over
People
60
Run by
Marco Mazzola
See details and how to joinNCT07427160
No phaseNot yet taking people in Olaszország
Mirabegron in Patients With Age-Related Macular Degeneration
Where
Naples
Életkor
50 év to 80 év
People
312
Run by
University of Naples
See details and how to joinNCT07305298
No phaseTaking people
Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma
Where
Rome
Életkor
65 év and over
People
36
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT05706896
No phaseTaking people
Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.
Where
Rome
Életkor
65 év and over
People
36
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06536062
No phaseTaking people
Lutein by Scleral Iontophoresis in AMD
Where
Naples
Életkor
55 év to 100 év
People
80
Run by
Federico II University
See details and how to joinNCT06925893
No phaseTaking people
Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.
Where
Udine
Életkor
50 év to 120 év
People
200
Run by
University of Udine
See details and how to joinNCT06899360
No phaseTaking people
Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
Where
Genova, Milan, Rome
Életkor
55 év and over
People
50
Run by
Ospedale San Raffaele
See details and how to joinNCT04847635
No phaseTaking people
A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
Where
Bergamo
Életkor
50 év and over
People
30
Run by
Oculox Technologies SA
See details and how to joinNCT06557369